Olumide Ogundahunsi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Olumide Ogundahunsi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A.O. Adesina
Common Heritage Foundation, Box 5124, Yola, Nigeria
1 shared publicationAashka Sethi Sood
Affiliation Bruyère Health Research Institute, Ottawa, Canada
1 shared publicationAfzaa Rajabali
Affiliation Bruyère Health Research Institute, Ottawa, Canada
1 shared publication- Alison Krentel
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
1 shared publication - Carol McPhillips-Tangum
Affiliation CMT Consulting, LLC, Atlanta, Georgia, United States of America
1 shared publication - David Anuoluwapo Oyeniran
Laboratory for Experimental and Translational Neurobiology, University of Medical Sciences, Ondo City, 351101, Ondo State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 29 September 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (9) , e0005186
Opportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study
In low- and middle-income countries, health campaigns play a crucial role in addressing high-priority health concerns such as neglected tropical diseases (NTDs), malaria, vaccine-preventable diseases and nutrition (vitamin A supplementation). Many health campaigns are conducted throughout the calendar year, resulting in multiple campaigns annually in some communities. Campaign integration offers an opportunity to increase efficiencies across programs and limit the strain on healthcare workers, communities, and health systems. The response to the COVID-19 pandemic provided opportunities for campaign integration to mitigate losses from missed campaign deliveries. As the interest in integration grows, there is a need to understand existing barriers, bottlenecks, and opportunities for better integration, whether through co-delivery or increased collaboration. This qualitative study aimed to understand the opportunities and barriers to campaign co-delivery and collaboration from the perspective of 26 stakeholders involved in vaccine-preventable diseases, vitamin A supplementation, NTDs, and malaria programs. Key informants included campaign managers, implementing partners, donors, and decision-makers at the country and state levels in five countries: Côte d’Ivoire, Ethiopia, Guyana, Indonesia, and Nigeria. Results indicated that campaigns were integrated at various levels, from partial integration and co-delivery to fully integrated delivery within existing health services. Most emerging factors were categorized as either facilitating or hindering campaign integration. Enablers to campaign integration included joint planning and appreciation for human resources, while target population variation, prioritization of one intervention by another, and overburdening of healthcare workers, community health workers and community drug distributors were identified as specific barriers. An emerging theme was the importance of leadership, reinforcing the need for country ownership, political will, and positive stakeholder relationships. Further research is warranted to identify optimal combinations of campaign commodities, strategies to ensure stakeholder engagement throughout the integration process, methods to factor in local community context, and the expansion of lessons learned from the COVID-19 pandemic.
- 29 September 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (9) , e0005186
Open AccessOpportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study
In low- and middle-income countries, health campaigns play a crucial role in addressing high-priority health concerns such as neglected tropical diseases (NTDs), malaria, vaccine-preventable diseases and nutrition (vitamin A supplementation). Many health campaigns are conducted throughout the calendar year, resulting in multiple campaigns annually in some communities. Campaign integration offers an opportunity to increase efficiencies across programs and limit the strain on healthcare workers, communities, and health systems. The response to the COVID-19 pandemic provided opportunities for campaign integration to mitigate losses from missed campaign deliveries. As the interest in integration grows, there is a need to understand existing barriers, bottlenecks, and opportunities for better integration, whether through co-delivery or increased collaboration. This qualitative study aimed to understand the opportunities and barriers to campaign co-delivery and collaboration from the perspective of 26 stakeholders involved in vaccine-preventable diseases, vitamin A supplementation, NTDs, and malaria programs. Key informants included campaign managers, implementing partners, donors, and decision-makers at the country and state levels in five countries: Côte d’Ivoire, Ethiopia, Guyana, Indonesia, and Nigeria. Results indicated that campaigns were integrated at various levels, from partial integration and co-delivery to fully integrated delivery within existing health services. Most emerging factors were categorized as either facilitating or hindering campaign integration. Enablers to campaign integration included joint planning and appreciation for human resources, while target population variation, prioritization of one intervention by another, and overburdening of healthcare workers, community health workers and community drug distributors were identified as specific barriers. An emerging theme was the importance of leadership, reinforcing the need for country ownership, political will, and positive stakeholder relationships. Further research is warranted to identify optimal combinations of campaign commodities, strategies to ensure stakeholder engagement throughout the integration process, methods to factor in local community context, and the expansion of lessons learned from the COVID-19 pandemic.
- Top Cited PapersOpen Access
Glial Perturbation in Metal Neurotoxicity: Implications for Brain Disorders
Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.
Top Cited PapersOpen AccessGlial Perturbation in Metal Neurotoxicity: Implications for Brain Disorders
Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.
- Open Access
- 1 March 2012
- Published by Oxford University Press (OUP) in International Health
- Vol. 4 (1) , 10-19
Nomadic Fulani communities manage malaria on the move
As in other public health efforts, the current promotion of insecticide-treated net (ITN) usage and prompt treatment of malaria has left the nomadic populations behind. The hypothesis that nomads can apply the community-directed intervention (CDI) strategy for fever management in children under-5 was tested among nomadic Fulani communities in northeastern Nigeria. Twenty camps selected representatives who were trained to provide artemisinin-based combination therapy and ITNs to their members. Coverage was compared with existing practice in 20 other nomadic Fulani communities. At baseline, none of the camps had ITNs, and antimalarial usage was only 2.7% in intervention camps and 5.8% in comparison camps. The nomads redesigned the negotiated intervention delivery approach to suit their culture. Within 12 months antimalarial usage and appropriate management of malaria in children under-5 reached 88.0% and 81.7%, respectively, and within 24 months they reached 87.9% and 86.1%, respectively, surpassing the Roll Back Malaria target of 80% coverage by 2011. In contrast, usage was <5% in the comparison camps. ITN possession reached 66.7% and 73.2% in the first and second years, respectively, within intervention camps, but was unchanged in comparison camps. However, ITN usage remained low at 21.7% in the second year (P < 0.05). When empowered, nomads will appropriately manage malaria using the CDI approach.
- 1 March 2012
- Published by Oxford University Press (OUP) in International Health
- Vol. 4 (1) , 10-19
Open AccessNomadic Fulani communities manage malaria on the move
As in other public health efforts, the current promotion of insecticide-treated net (ITN) usage and prompt treatment of malaria has left the nomadic populations behind. The hypothesis that nomads can apply the community-directed intervention (CDI) strategy for fever management in children under-5 was tested among nomadic Fulani communities in northeastern Nigeria. Twenty camps selected representatives who were trained to provide artemisinin-based combination therapy and ITNs to their members. Coverage was compared with existing practice in 20 other nomadic Fulani communities. At baseline, none of the camps had ITNs, and antimalarial usage was only 2.7% in intervention camps and 5.8% in comparison camps. The nomads redesigned the negotiated intervention delivery approach to suit their culture. Within 12 months antimalarial usage and appropriate management of malaria in children under-5 reached 88.0% and 81.7%, respectively, and within 24 months they reached 87.9% and 86.1%, respectively, surpassing the Roll Back Malaria target of 80% coverage by 2011. In contrast, usage was <5% in the comparison camps. ITN possession reached 66.7% and 73.2% in the first and second years, respectively, within intervention camps, but was unchanged in comparison camps. However, ITN usage remained low at 21.7% in the second year (P < 0.05). When empowered, nomads will appropriately manage malaria using the CDI approach.